KVUE.NYSEKenvue INC

Form 4: Kenvue Director Receives Deferred Share Units

Sentiment:

Insider Transaction Report


Kenvue Inc. director Kathleen M. Pawlus was granted 10,309 Deferred Share Units on May 21, 2026, under the company's director compensation plan.

Summary

  • Kathleen M. Pawlus, a Director at Kenvue Inc., received a grant of 10,309 Deferred Share Units (DSUs) on May 21, 2026.
  • These DSUs are part of the Issuer's Amended and Restated Deferred Fee Plan for Directors.
  • Each DSU represents the right to receive one share of Kenvue's common stock.
  • The settlement of these DSUs will occur upon the termination of Ms. Pawlus's directorship.
  • The filing also notes that the total number of DSUs beneficially owned by Ms. Pawlus following this transaction is 25,037.675, which includes DSUs acquired as dividend equivalents.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director and does not provide new financial performance data or strategic shifts.

Positives

  • Director compensation aligns with long-term commitment to the company through deferred share units.
  • The grant of DSUs indicates continued confidence in the company's future prospects by a board member.
  • Dividend equivalents on DSUs demonstrate a mechanism for directors to benefit from stock performance even on deferred compensation.

Negatives

  • The filing does not contain any negative financial or operational information.

Risks

  • The value of the deferred share units is subject to the future market price of Kenvue Inc. common stock.
  • Potential for changes in Kenvue's stock performance impacting the ultimate value received by the director.

Future Outlook

The future outlook for the value of the granted DSUs is tied to the performance of Kenvue Inc. common stock, which will be settled upon the reporting person's termination of directorship.

Industry Context

StockSavvy.ai notes that the issuance of Deferred Share Units to directors is a common practice in the pharmaceutical and consumer health sectors, aligning director compensation with shareholder value and encouraging long-term strategic thinking.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation PlanGrant of Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.05/21/2026Standard practice for director compensation, aligning incentives with long-term company performance.

Related Party Transactions

  • Grant of Deferred Share Units to Director Kathleen M. Pawlus.

Stakeholder Impact

  • Shareholders: The grant of DSUs is a form of compensation and does not immediately dilute share count, but future settlement will result in the issuance of shares.
  • Employees: No direct impact.
  • Management: Standard compensation practice for board members.
  • Creditors: No direct impact.

Next Steps

  • Settlement of Deferred Share Units upon termination of Kathleen M. Pawlus's directorship.

Key Dates

DateDescription
05/21/2026Transaction Date: Grant of Deferred Share Units
05/26/2026Date of Report (Signature Date)

Keywords

Kenvue Inc., KVUE, Form 4, Director, Deferred Share Units, DSU, Stock Grant, Beneficial Ownership, SEC Filing, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.